U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
128461128461Cross-linked Hyaluronan Gel Reduces Rectal Toxicity Due to Radiation Therapy for Prostate CancerCompletedNo Results AvailableProstate CancerDevice: Cross-linked hyaluronan gelhttps://ClinicalTrials.gov/show/NCT00882232
128462128462Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up PeriodCompletedNo Results AvailableCoronary RestenosisDevice: Xience V®https://ClinicalTrials.gov/show/NCT00882219
128463128463Decitabine, Vorinostat, and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma That Has Relapsed or Not Responded to TreatmentCompletedNo Results AvailableLeukemia|LymphomaDrug: cytarabine|Drug: decitabine|Drug: doxorubicin hydrochloride|Drug: imatinib mesylate|Drug: methotrexate|Drug: pegaspargase|Drug: prednisone|Drug: vincristine sulfate|Drug: vorinostathttps://ClinicalTrials.gov/show/NCT00882206
128464128464Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/RelapsersTerminatedNo Results AvailableChronic Hepatitis C|Genotype 1|RelapseDrug: Betaine|Drug: Peginterferon alpha 2a|Drug: Ribavirinhttps://ClinicalTrials.gov/show/NCT00882193
128465128465Dose Escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous ALN-VSP02 In Patients With Advanced Solid Tumors With Liver InvolvementCompletedNo Results AvailableSolid TumorsDrug: ALN-VSP02https://ClinicalTrials.gov/show/NCT00882180
128466128466Cine-magnetic Resonance Imaging (MRI) Detecting Intra Abdominal AdhesionsRecruitingNo Results AvailableTissue AdhesionsOther: CineMRIhttps://ClinicalTrials.gov/show/NCT00882167
128467128467To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 300 mg Capsule Fed ConditionsCompletedNo Results AvailableHealthyDrug: Cefdinir 300 mg Capsule (Sandoz, Austria)|Drug: Omnicef Cefdinir 300 mg Capsule (Abbott Laboratories, USA)https://ClinicalTrials.gov/show/NCT00882154
128468128468Race, Menopause and Metabolism After Exercise and DietCompletedNo Results AvailableObesity|Insulin Resistance|Sedentary LifestyleBehavioral: Diet modification|Behavioral: Aerobic exercisehttps://ClinicalTrials.gov/show/NCT00882141
128469128469Evaluation of the Control Level of Asthmatic Patients With Seasonal Increase of Respiratory Symptoms (High and/or Low)CompletedNo Results AvailableAsthma|Respiratory Symptomshttps://ClinicalTrials.gov/show/NCT00882128
128470128470Broccoli Sprout Extract Effects on Allergic Inflammation in the NoseCompletedNo Results AvailableAllergic Airway DiseaseDrug: Broccoli sprout extracthttps://ClinicalTrials.gov/show/NCT00882115
128471128471Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS)CompletedHas ResultsAcute Myelogenous Leukemia|Myelodysplastic SyndromeDrug: Decitabine|Drug: Gemtuzumab ozogamicinhttps://ClinicalTrials.gov/show/NCT00882102
128472128472Use of the Conturaâ„¢ Catheter in Intermediate-Risk, Pathological Stage 0, I, or II (Up to 3.0 cm) Breast Cancer PatientsCompletedNo Results AvailableBreast CancerDevice: Contura catheterhttps://ClinicalTrials.gov/show/NCT00882089
128473128473Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute LeukemiasCompletedNo Results AvailableLeukemiaDrug: Etoposide, Mitoxantrone, Clofarabine|Drug: Clofarabine, Etoposide, Mitoxantronehttps://ClinicalTrials.gov/show/NCT00882076
128474128474Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple MyelomaCompletedNo Results AvailableRelapsed and/or Refractory Multiple MyelomaDrug: P276-00https://ClinicalTrials.gov/show/NCT00882063
128475128475Intravenous Exenatide (Byetta) During SurgeryRecruitingNo Results AvailableEuglycemia|Hypoglycemia|HyperglycemiaDrug: Exenatide|Drug: Exenatide|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00882050
128476128476Risk and Protective Factors for Rural Methamphetamine DependenceEnrolling by invitationNo Results AvailableMethamphetamine Dependencehttps://ClinicalTrials.gov/show/NCT00882037
128477128477Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA)CompletedNo Results AvailableActive Rheumatoid ArthritisDrug: Tranilast|Drug: Tranilast|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00882024
128478128478Observational Controlled Clinical Trials, on Adult Patients With T-lymphoblastic Lymphoma Treated With Intensive Chemo/Radiotherapy or Intensive Chemotherapy Followed by Transplant. Evaluation of Clinical, Anatomy -Pathological ParametersRecruitingNo Results AvailableLymphoblastic LymphomaOther: Latest generation chemotherapies for T-LBL + transplanthttps://ClinicalTrials.gov/show/NCT00882011
128479128479Study of Two Surgical Approaches for Total Hip ArthroplastyCompletedNo Results AvailableTotal Hip ArthroplastyProcedure: Minimally Invasive Total Hip Arthroplasty|Procedure: Conventional Total Hip Arthroplastyhttps://ClinicalTrials.gov/show/NCT00881998
128480128480Effect of Continuous Positive Airway Pressure for Treatment of Obstructive Sleep Apnea on Resistant HypertensionRecruitingNo Results AvailableResistant Hypertension|Obstructive Sleep ApneaDevice: continuous positive airway pressurehttps://ClinicalTrials.gov/show/NCT00881985
128481128481Physical Activity and Glycemic ControlCompletedNo Results AvailableInsulin ResistanceBehavioral: Exercisehttps://ClinicalTrials.gov/show/NCT00881972
128482128482Study of Root Coverage With Acellular Dermal Matrix: Puros® Dermis Versus Alloderm®CompletedHas ResultsGingival RecessionDevice: Puros® Dermis versus Alloderm®https://ClinicalTrials.gov/show/NCT00881959
128483128483Repeat Dose Safety Study for Compound to Treat Hematologic CancerCompletedNo Results AvailableHematologic MalignanciesDrug: GSK21110183https://ClinicalTrials.gov/show/NCT00881946
128484128484Study of Fludarabine + Cyclophosphamide + TBI Conditioning Regimen for Double Units Cord Blood Transplantation(CBT)in Severe Aplastic Anemia(SAA)RecruitingNo Results AvailableAplastic AnemiaOther: Cyclophosphosphamide, TBIhttps://ClinicalTrials.gov/show/NCT00881933
128485128485Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALLActive, not recruitingNo Results AvailableLymphoma|Myeloma|LeukemiaBiological: Kappa CD28 T cellshttps://ClinicalTrials.gov/show/NCT00881920
128486128486Tissue Characterization in Teeth Treated With a Regeneration ProtocolCompletedNo Results AvailablePulp NecrosisDrug: Triple Antibiotic Paste|Drug: Triple Antibiotic Paste|Drug: Triple Antibiotic Pastehttps://ClinicalTrials.gov/show/NCT00881907
128487128487Study in Healthy Volunteers to Prove That 2 Rotigotine Patches From Different Manufacturing Processes Deliver Equivalent Drug Amount to the Body.CompletedHas ResultsHealthyDrug: Rotigotine transdermal patchhttps://ClinicalTrials.gov/show/NCT00881894
128488128488Study Evaluating the Clinical and Therapeutic Management of Rheumatoid Arthritis in SpainCompletedNo Results AvailableRheumatoid Arthritishttps://ClinicalTrials.gov/show/NCT00881881
128489128489Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the ScalpCompletedHas ResultsScalp PsoriasisDrug: clobetasol propionate spray 0.05%|Drug: Vehicle sprayhttps://ClinicalTrials.gov/show/NCT00881868
128490128490To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fed ConditionsCompletedNo Results AvailableHealthyDrug: Cefprozil 500 mg Tablets (Sandoz, GmbH)|Drug: Cefzil (Cefprozil) 500 mg Tablets (Bristol-Myers Squibb, USA)https://ClinicalTrials.gov/show/NCT00881855

* Görseller ve İçerik tekif hakkına sahip olabilir